Dextran-based Priming vs. Crystalloid and Mannitol-based Priming Solution in Adult Cardiac Surgery - Trial NCT02767154
Access comprehensive clinical trial information for NCT02767154 through Pure Global AI's free database. This Phase 2 trial is sponsored by Sahlgrenska University Hospital, Sweden and is currently Completed. The study focuses on Heart Disease. Target enrollment is 84 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Sahlgrenska University Hospital, Sweden
Timeline & Enrollment
Phase 2
May 01, 2016
Jul 13, 2017
Primary Outcome
Change in oncotic pressure in plasma
Summary
This study will compare two priming solutions for extracorporeal circulation, one based on
 Dextran 40, one based on crystalloid and mannitol. Primary endpoint is oncotic pressure
 during cardiopulmonary bypass. Secondary endpoints included fluid balance and organ
 functions.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT02767154
Device Trial